Table 5.

Grade 3–4 toxicities

Complication (multiple possible per patient)	Days post-RE	Study group	Control group
Post-SIRT radioembolization syndrome	1–90 days	1/22 (5%)	4/58 (7%)
Grade 3 abdominal pain/distension	10–12 days	1/22 (5%)	2/58 (3%)
Grade 3 fevers	3 days	0	1/58 (2%)
Acute liver failure/failure to thrive/grade 3 hyperbilirubinemia	14 days	0	1/58 (2%)
Grade 3 dyspnea	30 days	0	1/58(2%)
Bile duct obstruction + Budd-Chiari syndrome + stop chemotherapy for 6 weeks	1 day/60 days	1/22 (5%)	0
Total patients number		2/22 (9%)	9/58 (16%)